0001636282-26-000030.txt : 20260403 0001636282-26-000030.hdr.sgml : 20260403 20260403213011 ACCESSION NUMBER: 0001636282-26-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260401 FILED AS OF DATE: 20260403 DATE AS OF CHANGE: 20260403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sloan Sheldon CENTRAL INDEX KEY: 0002038798 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 26839443 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spyre Therapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6176515940 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Aeglea BioTherapeutics, Inc. DATE OF NAME CHANGE: 20150311 4 1 wk-form4_1775266209.xml FORM 4 X0609 4 2026-04-01 0 0001636282 Spyre Therapeutics, Inc. SYRE 0002038798 Sloan Sheldon false 221 CRESCENT STREET, BUILDING 23 SUITE 105 WALTHAM MA 02453 0 1 0 0 Chief Medical Officer 1 Common Stock 2026-04-01 4 M 0 7958 21.66 A 7958 D Common Stock 2026-04-01 4 S 0 7958 50 D 0 D Stock Option (Right to Buy) 21.66 2026-04-01 4 M 0 7958 0 D 2035-01-15 Common Stock 7958 87542 D This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025. This option represents a right to purchase 95,500 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date. /s/ Heidy King-Jones, as Attorney-in-Fact 2026-04-03